Steven L Chen1, Steve R Martinez. 1. Department of Surgery, Division of Surgical Oncology, University of California Davis Medical Center, 4501 X St., Suite 3010, Sacramento, CA 95817, USA. slwchen@ucdinis.edu
Abstract
BACKGROUND: Many women with breast cancer recurrence previously treated with breast-conservation therapy desire repeat lumpectomies. We hypothesized that women undergoing mastectomy for breast cancer recurrence would show superior survival. METHODS: Patients who previously received breast-conservation therapy diagnosed with an ipsilateral breast cancer recurrence between 1988 and 2004 were identified using the Surveillance, Epidemiology, and End Results database. Univariate survival analysis was performed using the Kaplan-Meier method. Cox regression was used for multivariate analysis. RESULTS: Criteria for analysis were met in 747 patients. Of those, 24% underwent lumpectomy. On univariate analysis, patients undergoing lumpectomy had worse overall survival (P = .03). Five-year survival was 67% versus 78% for the lumpectomy and mastectomy groups, respectively. On multivariate analysis, mastectomy remained significantly associated with better survival with a hazard ratio of .5 (P = .003). CONCLUSIONS: The use of lumpectomy for ipsilateral breast cancer recurrence previously treated with breast-conservation therapy should generally be discouraged.
BACKGROUND: Many women with breast cancer recurrence previously treated with breast-conservation therapy desire repeat lumpectomies. We hypothesized that women undergoing mastectomy for breast cancer recurrence would show superior survival. METHODS:Patients who previously received breast-conservation therapy diagnosed with an ipsilateral breast cancer recurrence between 1988 and 2004 were identified using the Surveillance, Epidemiology, and End Results database. Univariate survival analysis was performed using the Kaplan-Meier method. Cox regression was used for multivariate analysis. RESULTS: Criteria for analysis were met in 747 patients. Of those, 24% underwent lumpectomy. On univariate analysis, patients undergoing lumpectomy had worse overall survival (P = .03). Five-year survival was 67% versus 78% for the lumpectomy and mastectomy groups, respectively. On multivariate analysis, mastectomy remained significantly associated with better survival with a hazard ratio of .5 (P = .003). CONCLUSIONS: The use of lumpectomy for ipsilateral breast cancer recurrence previously treated with breast-conservation therapy should generally be discouraged.
Authors: Steve R Martinez; Shannon H Beal; Robert J Canter; Steven L Chen; Vijay P Khatri; Richard J Bold Journal: Med Oncol Date: 2011-09 Impact factor: 3.064
Authors: Min Yi; Elizabeth A Mittendorf; Janice N Cormier; Thomas A Buchholz; Karl Bilimoria; Aysegul A Sahin; Gabriel N Hortobagyi; Ana Maria Gonzalez-Angulo; Sheng Luo; Aman U Buzdar; Jaime R Crow; Henry M Kuerer; Kelly K Hunt Journal: J Clin Oncol Date: 2011-11-14 Impact factor: 44.544
Authors: Min Yi; Sharon Hermes Giordano; Funda Meric-Bernstam; Elizabeth A Mittendorf; Henry M Kuerer; Rosa F Hwang; Isabelle Bedrosian; Loren Rourke; Kelly K Hunt Journal: Ann Surg Oncol Date: 2010-09-19 Impact factor: 5.344
Authors: Jessica Chubak; Onchee Yu; Gaia Pocobelli; Lois Lamerato; Joe Webster; Marianne N Prout; Marianne Ulcickas Yood; William E Barlow; Diana S M Buist Journal: J Natl Cancer Inst Date: 2012-04-30 Impact factor: 13.506
Authors: Soo Yeon Baek; Jisun Kim; Il Yong Chung; Beom Seok Ko; Hee Jeong Kim; Jong Won Lee; Byung Ho Son; Sei-Hyun Ahn; Sae Byul Lee Journal: Breast Cancer Res Treat Date: 2020-09-15 Impact factor: 4.872
Authors: Shannon H Beal; Steve R Martinez; Robert J Canter; Steven L Chen; Vijay P Khatri; Richard J Bold Journal: Med Oncol Date: 2010-01-05 Impact factor: 3.064